Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistanceRuifen Tian, Xia Song, Xing Zhang et al.|Pakistan Journal of Medical Sciences|2024Cited by 0